BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 26810510)

  • 1. Ingested (oral) anti-IL-12/23 inhibits EAE.
    Brod SA
    J Neurol Sci; 2016 Feb; 361():19-25. PubMed ID: 26810510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ingested (oral) thyrotropin releasing factor (TRH) inhibits EAE.
    Brod SA; Bauer V
    Cytokine; 2013 Jan; 61(1):323-8. PubMed ID: 23148993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ingested (oral) tocilizumab inhibits EAE.
    Brod SA; Bauer VL
    Cytokine; 2014 Aug; 68(2):86-93. PubMed ID: 24845797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ingested (oral) neuropeptide Y inhibits EAE.
    Brod SA; Bauer VL
    J Neuroimmunol; 2012 Sep; 250(1-2):44-9. PubMed ID: 22703767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ingested (oral) SST inhibits EAE.
    Brod SA; Hood ZM
    Autoimmunity; 2011 Aug; 44(5):437-43. PubMed ID: 21244338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ingested (oral) rituximab inhibits EAE.
    Brod SA
    Cytokine; 2016 Sep; 85():177-83. PubMed ID: 27372916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ingested (oral) ACTH inhibits EAE.
    Brod SA; Hood ZM
    J Neuroimmunol; 2011 Mar; 232(1-2):131-5. PubMed ID: 21081248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invariant NKT cells producing IL-4 or IL-10, but not IFN-gamma, inhibit the Th1 response in experimental autoimmune encephalomyelitis, whereas none of these cells inhibits the Th17 response.
    Oh SJ; Chung DH
    J Immunol; 2011 Jun; 186(12):6815-21. PubMed ID: 21572032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression.
    Imler TJ; Petro TM
    Int Immunopharmacol; 2009 Jan; 9(1):134-43. PubMed ID: 19022403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ingested (oral) SIRS peptide 1-21 inhibits acute EAE by inducing Th2-like cytokines.
    Brod SA; Hood Z
    J Neuroimmunol; 2007 Feb; 183(1-2):89-95. PubMed ID: 17196668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The flavonoid kurarinone inhibits clinical progression of EAE through inhibiting Th1 and Th17 cell differentiation and proliferation.
    Xie L; Gong W; Chen J; Xie HW; Wang M; Yin XP; Wu W
    Int Immunopharmacol; 2018 Sep; 62():227-236. PubMed ID: 30031314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
    Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
    Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ingested (oral) alpha-MSH inhibits acute EAE.
    Brod SA; Hood ZM
    J Neuroimmunol; 2008 Jan; 193(1-2):106-12. PubMed ID: 18037504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adoptive transfer from interferon-alpha-fed mice is associated with inhibition of active experimental autoimmune encephalomyelitis by decreasing recipient tumor necrosis factor-alpha secretion.
    Brod SA; Khan M; Nelson LD; Decuir B; Malone M; Henninger E
    J Immunother; 2000; 23(2):235-45. PubMed ID: 10746550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laquinimod, a quinoline-3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity.
    Schulze-Topphoff U; Shetty A; Varrin-Doyer M; Molnarfi N; Sagan SA; Sobel RA; Nelson PA; Zamvil SS
    PLoS One; 2012; 7(3):e33797. PubMed ID: 22479444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of IL-10 and IL-17 mediated experimental autoimmune encephalomyelitis by S-nitrosoglutathione.
    Singh I; Nath N; Saxena N; Singh AK; Won JS
    Immunobiology; 2018 Oct; 223(10):549-554. PubMed ID: 29960806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ingested ACTH blocks Th17 production by inhibiting GALT IL-6.
    Dittel LJ; Dittel BN; Brod SA
    J Neurol Sci; 2020 Feb; 409():116602. PubMed ID: 31812846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E and its mimetic peptide suppress Th1 and Th17 responses in experimental autoimmune encephalomyelitis.
    Wei J; Zheng M; Liang P; Wei Y; Yin X; Tang Y; Xue Y
    Neurobiol Dis; 2013 Aug; 56():59-65. PubMed ID: 23619428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ingested (oral) adrenocorticotropic hormone (ACTH) inhibits interleukin-17 in the central nervous system after adoptive transfer of T helper (Th)1/Th17 T cells in the mouse model of multiple sclerosis, experimental autoimmune encephalomyelitis.
    Dittel LJ; Dittel BN; Brod SA
    J Neurol Sci; 2024 Jan; 456():122779. PubMed ID: 38070316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-12/IL-23p40 Is Highly Expressed in Secondary Lymphoid Organs and the CNS during All Stages of EAE, but Its Deletion Does Not Affect Disease Perpetuation.
    Cravens PD; Hussain RZ; Miller-Little WA; Ben LH; Segal BM; Herndon E; Stüve O
    PLoS One; 2016; 11(10):e0165248. PubMed ID: 27780253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.